Clinical Trials · NCT02635386
EQW, DAPA, EQW/DAPA, DAPA/MET ER and PHEN/TPM ER in Obese Women With PolycysticOvary Syndrome (PCOS)
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Woman's
- Enrollment
- 119
- Start date
- Mar 2016
- Locations
- 1 site, United States
- Primary endpoint
- Oral Disposition (Insulin Sensitivity-insulin Secretion) Index